NIH is working to develop a vaccine, identify existing therapeutics and encourage research to address the coronavirus outbreak that began in China in late 2019.
Current issue: Jan / Feb 2020 Global Health Matters newsletter
COVID-19 is an emerging, rapidly evolving situation.
Fogarty Director Dr. Roger I. Glass discusses how building trust in vaccines is essential for global health, while reflecting on the legacy of his late colleague, vaccine developer Dr. Maharaj K. Bhan.
Fogarty Fellow Jillian Armstrong is studying use of a novel malaria detection device in Cameroon.
Over the decades, Fogarty has made significant contributions by filling the pipeline of global health leaders, extending the frontiers of science and accelerating discovery.
“By establishing training programs in these underserved areas, we could recruit locally, which improved retention of trainees who would practice at home and give back to their local communities.”Dr. Jean NachegaFogarty grantee
Many of NIH's 27 Institutes and Centers are engaged in global health activities.
Dr. Dongkyun Kang and his partners in Uganda are exploring the use of an innovative microscope to enable early cancer diagnoses with support from NCI, NIAID and Fogarty.
Fogarty and its NIH partners invest in a variety of research topics vital to global health.
Mobile health (mHealth) news, resources and funding for global health researchers